First Trust Advisors
VYGR icon

First Trust Advisors’s Voyager Therapeutics VYGR Stock Holding History

First Trust Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-120,734
Closed -$955K – 2493
2024
Q2 		$955K Sell
120,734
-17,395
-13% -$146K ﹤0.01% 1963
2024
Q1 		$1.29M Buy
138,129
+52,290
+61% +$441K ﹤0.01% 1906
2023
Q4 		$724K Buy
85,839
+2,219
+3% +$16.1K ﹤0.01% 2054
2023
Q3 		$648K Buy
+83,620
New +$764K ﹤0.01% 2091

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Trust Advisors's VYGR Position: Q3 2024 in Review

First Trust Advisors sold out of Voyager Therapeutics (VYGR) in Q3 2024, closing a stake of 120,734 shares — an estimated $955K sold.

First Trust Advisors first reported a position in VYGR in Q3 2023 and held it in 4 quarters. The position peaked at $1.29M in Q1 2024. 128 funds tracked by Wall St. Rank hold VYGR as of Q3 2024.

  • First Trust Advisors reported no remaining Voyager Therapeutics position as of Q3 2024 after selling out during the quarter.
  • First Trust Advisors sold 120,734 Voyager Therapeutics shares in Q3 2024, an estimated $955K.
  • First Trust Advisors first reported a position in Voyager Therapeutics in Q3 2023 and held it in 4 quarters.
  • First Trust Advisors's Voyager Therapeutics position peaked at $1.29M in Q1 2024.
  • 128 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2024.

Based on First Trust Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.